Sander Gerber

CIK 1416593 · last filed 2023-09-14

Sander Gerber is a corporate insider who has filed 14 SEC Form 4 insider transactions across 10 companies since 2015. The most recent filing, for CLDI.WS, was dated Sep 14, 2023. Across all open-market trades the lifetime net is −$12.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions. 66 SEC filings were submitted jointly with Hudson Bay Capital Management LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.76M

Companies

10

Total Filings

14

Lifetime Open-Market Net

-$12.76M

Filer Profile

Reported Address
C/O HUDSON BAY CAPITAL MANAGEMENT, L.P.
28 HAVEMEYER PLACE, 2ND FLOOR
GREENWICH, CT 06830
Related Filers
Hudson Bay Capital Management LP — 66 joint filings, latest 2023-09-14
Hudson Bay Credit Management LLC — 7 joint filings, latest 2015-10-19
Hudson Bay Overseas Fund Ltd. — 5 joint filings, latest 2009-10-06
Hudson Bay Master Fund Ltd. — 4 joint filings, latest 2020-03-26
Galena Biopharma, Inc. — 2 joint filings, latest 2017-02-10
HWH International Inc. — 2 joint filings, latest 2023-05-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted 10%+ Owner 0 $0.01 $0 $0 1 2023-09-14
Greencity Acquisition Corp (GRCYW) Delisted 10%+ Owner 0 $0.02 $0 $0 1 2023-04-27
REVIVA PHARMACEUTICALS HOLDINGS, INC. (TZACW) Delisted 10%+ Owner 0 -$1.15M 1 2020-12-09
ADVENT TECHNOLOGIES HOLDINGS, INC. (AMCIW) Delisted 10%+ Owner 1,000,000 $0.33 $330.1K $0 1 2020-10-20
TDACW 10%+ Owner 1,100,000 $1.60 $1.76M -$574.1K 4 2020-09-02
Longevity Acquisition Corp (LOACU) Delisted 10%+ Owner 580,000 -$815.6K 1 2018-09-13
Priority Technology Holdings, Inc. (MACQW) Delisted 10%+ Owner 552,293 $0.87 $480.5K -$4.19M 1 2018-07-13
ISUN, INC. (JSYNW) Delisted 10%+ Owner 0 $0 1 2018-06-08
SELLAS Life Sciences Group, Inc. (GALE) Delisted 10%+ Owner 67,885 -$3.97M 1 2017-02-10
INNOVATE Corp. (HCHC) Delisted 10%+ Owner 776,372 $3.68 $2.86M -$2.06M 1 2015-10-13

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-09-14 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Other (J) −1,000,000 -$10.49M EDGAR
2023-04-27 Greencity Acquisition Corp (GRCYW) Delisted Other (J) −650,000 -$6.50M EDGAR
2020-12-09 REVIVA PHARMACEUTICALS HOLDINGS, INC. (TZACW) Delisted Mixed −1,520,000 -$16.60M EDGAR
2020-10-20 ADVENT TECHNOLOGIES HOLDINGS, INC. (AMCIW) Delisted Other (J) −3,202,200 -$32.98M EDGAR
2020-09-02 TDACW Other (J) −680,000 $0 EDGAR
2020-09-01 TDACW Other (J) −680,000 -$7.32M EDGAR
2020-07-15 TDACW Sell (S) −720,000 -$7.83M EDGAR
2020-07-14 TDACW Sell (S) +667,428 $7.26M EDGAR
2018-09-13 Longevity Acquisition Corp (LOACU) Delisted Sell (S) −80,000 -$815.6K EDGAR
2018-07-13 Priority Technology Holdings, Inc. (MACQW) Delisted Sell (S) −395,414 -$4.19M EDGAR
Showing 110 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.